Updated Jul 16, 2026 · Last SEC filing 2026-07-08
Neurogene Inc. (NGNE) has filed 5 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-08. 6 Form 8-K material event filings were reported by NGNE in the last 90 days. 1 Form 144 notices of proposed sale were filed for NGNE stock. InsiderAlpha tracks every NGNE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001404644 |
|---|
| Form 4 filings (90d) | 5 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-08 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 4.2K | $36.13 | $152K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 600 | $36.02 | $22K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 1.5K | $35.23 | $54K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 2.5K | $34.58 | $88K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 739 | $34.06 | $25K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 4.8K | $32.44 | $156K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 4.8K | $30.07 | $144K | SEC | |
| McMinn Rachel | Chief Executive Officer | S — Open-market sale | 3.4K | $22.07 | $74K | SEC | |
| Jordan Julie | Chief Medical Officer | S — Open-market sale | 828 | $21.89 | $18K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 2.6K | $21.62 | $55K | SEC | |
| Cobb Stuart | Chief Scientific Officer | S — Open-market sale [10b5-1] | 148 | $22.08 | $3K | SEC | |
| Cobb Stuart | Chief Scientific Officer | S — Open-market sale [10b5-1] | 4.0K | $20.41 | $81K | SEC | |
| Cobb Stuart | Chief Scientific Officer | S — Open-market sale [10b5-1] | 2.7K | $21.34 | $57K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 2.4K | $20.42 | $49K | SEC | |
| Cvijic Christine Mikail | President and CFO | S — Open-market sale | 1.4K | $21.25 | $30K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Neurogene Inc. (NGNE). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Cvijic Christine Mikail | 7 | $640K |
| Woods Keith | 1 | — |
| Shafer Christina | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NGNE insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live NGNE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.